Newamsterdam Pharma Co. NVNAMS
13F holders, Q1 2024 (March 31)76holders
3famous investors
$23.65avg. 13F price*
At the end of Q1 2024, 76 institutions reported holding Newamsterdam Pharma Co. NV (NAMS) in their 13F filings. The largest holders were Frazier Life Sciences Management, L.P. ($289.2M), FCPM III Services B.V. ($279.8M) and Bain Capital Life Sciences Investors, LLC ($247.7M). 3 famous investors held it, including Andreas Halvorsen (0.7% of Viking Global Investors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Newamsterdam Pharma Co. NV
- CUSIP
- N62509109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 47 | $229.0M |
| Exits | 2 | $6K |
Ownership 76 holders
| Frazier Life Sciences Management, L.P. | 12.23% | Add +0.8% | 12,226,943 | $289.2M |
| FCPM III Services B.V. | 39.56% | No change | 11,831,461 | $279.8M |
| Bain Capital Life Sciences Investors, LLC | 19.93% | No change | 10,473,913 | $247.7M |
| Viking Global Investors | 0.71% | No change | 8,024,565 | $189.8M |
| Ra Capital Management, L.P. | 2.37% | No change | 7,864,000 | $186.0M |
| Medicxi Ventures Management (Jersey) Ltd | 15.11% | No change | 2,869,565 | $67.9M |
| Adage Capital Partners Gp, L.L.C. | 0.08% | Add +40.4% | 1,824,601 | $43.2M |
| BVF Inc. | 0.99% | No change | 1,521,948 | $36.0M |
| Cormorant Asset Management, LP | 1.56% | New | 1,500,000 | $35.5M |
| Goldman Sachs Group Inc. | 0.01% | Reduce -7.3% | 1,283,455 | $30.4M |
| Polar Capital Holdings Plc | 0.16% | New | 1,252,586 | $29.6M |
| Millennium Management | 0.02% | Reduce -28.6% | 947,527 | $22.4M |
| GMT Capital Corp | 0.88% | Reduce -31.8% | 943,136 | $22.3M |
| Jennison Associates LLC | 0.01% | New | 930,851 | $22.0M |
| Artal Group S.A. | 0.49% | New | 800,000 | $18.9M |
| Deerfield Management Company, L.P. | 0.30% | New | 667,000 | $15.8M |
| Pictet Asset Management Holding SA | 0.02% | New | 649,736 | $15.4M |
| Janus Henderson Group PLC | 0.01% | New | 636,231 | $15.0M |
| Avidity Partners Management LP | 0.40% | New | 475,000 | $11.2M |
| Citadel Advisors | 0.01% | Add +2058.8% | 454,334 | $10.7M |
| Octagon Capital Advisors LP | 1.17% | New | 408,000 | $9.6M |
| Eversept Partners, LP | 0.63% | Reduce -5.5% | 353,965 | $8.4M |
| Opaleye Management Inc. | 1.64% | Add +18.8% | 315,388 | $7.5M |
| ArrowMark Colorado Holdings LLC | 0.08% | New | 296,807 | $7.0M |
| Affinity Asset Advisors, LLC | 1.19% | Add +129.0% | 286,200 | $6.8M |
| AXA S.A. | 0.02% | Reduce -9.8% | 249,251 | $5.9M |
| Ensign Peak Advisors, Inc | 0.01% | Add +28.2% | 246,106 | $5.8M |
| FMR LLC | 0.00% | New | 243,700 | $5.8M |
| TimesSquare Capital Management, LLC | 0.08% | New | 228,616 | $5.4M |
| Wellington Management Group LLP | 0.00% | New | 218,082 | $5.2M |
| Parkman Healthcare Partners LLC | 0.58% | Reduce -33.4% | 200,311 | $4.7M |
| Morgan Stanley | 0.00% | Add +522.3% | 177,588 | $4.2M |
| Nantahala Capital Management, LLC | 0.41% | New | 175,000 | $4.1M |
| Perceptive Advisors LLC | 0.07% | New | 175,000 | $4.1M |
| Monashee Investment Management LLC | 0.48% | New | 170,000 | $4.0M |
| Schonfeld Strategic Advisors LLC | 0.02% | Add +82.4% | 122,000 | $2.9M |
| Marshall Wace, LLP | 0.00% | Add +239.9% | 115,380 | $2.7M |
| Moody Aldrich Partners LLC | 0.45% | New | 111,267 | $2.6M |
| Silverarc Capital Management, LLC | 0.66% | New | 99,612 | $2.4M |
| Baker Bros. Advisors LP | 0.03% | New | 96,827 | $2.3M |
| Stempoint Capital LP | 0.51% | New | 80,334 | $1.9M |
| J. Goldman & Co LP | 0.08% | New | 78,834 | $1.9M |
| Artia Global Partners LP | 0.31% | New | 54,285 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +10.3% | 52,185 | $1.2M |
| Two Sigma Investments, LP | 0.00% | New | 51,675 | $1.2M |
| UBS Group AG | 0.00% | Add +5934.9% | 48,279 | $1.1M |
| Alyeska Investment Group, L.P. | 0.01% | New | 35,641 | $843K |
| Lighthouse Investment Partners, LLC | 0.04% | New | 29,357 | $694K |
| Y-Intercept (Hong Kong) Ltd | 0.05% | New | 26,208 | $620K |
| Gilder Gagnon Howe & Co. LLC | 0.01% | New | 24,466 | $579K |
| Yarbrough Capital, LLC | 0.02% | New | 23,960 | $567K |
| Cubist Systematic Strategies, LLC | 0.01% | New | 22,993 | $544K |
| Atle Fund Management AB | 0.32% | New | 22,394 | $530K |
| Sei Investments Co. | 0.00% | New | 16,474 | $390K |
| M&T Bank Corp | 0.00% | New | 15,738 | $372K |
| Cinctive Capital Management LP | 0.02% | New | 15,041 | $356K |
| Glenmede Trust Co. NA | 0.00% | New | 12,665 | $300K |
| Venture Visionary Partners LLC | 0.01% | Add +17.0% | 11,700 | $277K |
| BlackRock Inc. | 0.00% | Reduce -51.1% | 11,220 | $265K |
| Two Sigma Advisers, LP | 0.00% | New | 9,100 | $215K |
| Envestnet Asset Management Inc. | 0.00% | New | 9,039 | $214K |
| Wolverine Asset Management LLC | 0.01% | Reduce -18.0% | 7,130 | $169K |
| CIBC Private Wealth Group LLC | 0.00% | New | 7,640 | $163K |
| US Bancorp \de | 0.00% | New | 6,461 | $153K |
| JPMorgan Chase & Co. | 0.00% | New | 4,319 | $102K |
| Royal Bank of Canada | 0.00% | Reduce -68.3% | 3,450 | $82K |
| Bank of America Corp. | 0.00% | New | 2,000 | $47K |
| Canton Hathaway, LLC | 0.01% | New | 1,000 | $24K |
| Bradley & Co. Private Wealth Management, LLC | 0.01% | New | 729 | $17K |
| Signaturefd, LLC | 0.00% | New | 647 | $15K |
| PSI Advisors, LLC | 0.00% | New | 500 | $12K |
| Wells Fargo & Company | 0.00% | Add +66.7% | 500 | $12K |
| Stone House Investment Management, LLC | 0.00% | New | 325 | $8K |
| Barclays PLC | 0.00% | Reduce -81.7% | 94 | $2K |
| Principal Securities, Inc. | 0.00% | New | 5 | $118 |
| Dupont Capital Management Corp. | 0.00% | No change | 1 | $24 |
"% of holder's portfolio" is NAMS's weight in each manager's 13F, not the share of Newamsterdam Pharma Co. NV the manager owns.